IVF Clinic Comparison in 2026: How a 30% SART Success Rate Gap and $28K–$45K All-In Costs Should Drive Your Clinic Decision

You got quoted $15,000 for an IVF cycle. The clinic across town quoted $12,000. The one two hours away quoted $18,500. And all three told you some version of "our success rates are excellent."

Here's what none of them told you: the per-cycle live birth rate gap between the top and bottom quartile of SART-reporting clinics can exceed 30 percentage points for patients in your age bracket. And when you add up the real all-in cost — base fee, stimulation medications, monitoring, PGT-A genetic testing, and the frozen embryo transfer you'll statistically need — that $12K quote becomes $28K–$32K, while the $18.5K quote lands at $36K–$45K.

The real question isn't which clinic is cheapest. It's which clinic gives you the highest probability of live birth per dollar spent across the 1–3 cycles you're realistically facing.

Answering that question requires your personal variables: your age, your diagnosis, your AMH (anti-Müllerian hormone — the blood test that estimates your remaining egg supply), your prior cycle history, and your insurance situation. Let's build that framework.

The 30% Success Rate Gap Is Real — And Most Patients Never See It

SART (the Society for Assisted Reproductive Technology) publishes annual outcome data covering more than 450 reporting clinics. Feralyx's analysis of 2,880 rows of CDC ART IVF success rates data shows that for patients under 35, live birth rates per intended egg retrieval range from roughly 28% at lower-performing clinics to 58% at high performers within the same patient age cohort.

That gap doesn't disappear as you age — it narrows in absolute terms but grows in consequence. At 38, you're looking at roughly 15% to 38% per cycle across the clinic performance spectrum. At 41, 8% to 22%.

Why does the gap exist? Lab quality, embryologist experience and staffing ratios, embryo culture conditions, protocol customization, and the clinic's threshold for proceeding versus canceling a poor-responding cycle (the "cycle cancellation rate"). A clinic with a 14% cancellation rate — meaning they stopped 14 in 100 retrievals because the ovarian response wasn't sufficient — is not the same animal as one with a 4% cancellation rate, even if their reported live birth rate looks similar on the surface. Cancellation math hides underperformance. Clinics that cancel aggressively look better on paper because they only count cycles that made it to retrieval.

As detailed in IVF Clinic SART Data Comparison: How Cancellation Rates, a 30% Success Rate Gap, and a $15K–$28K Cost Spread Should Drive Your Clinic Decision in 2026, SART does publish cancellation data — but nearly zero patients look at it before choosing a clinic.

The All-In Cost Reality: $15K Quote → $28K–$45K Actual

Let's run the math that clinics don't run for you, using Feralyx's ivf_costs dataset (600 rows) and medication_costs dataset (240 rows), both sourced from FertilityIQ survey data.

Typical all-in cost breakdown per complete cycle:

Cost Component	Low End	High End
Base cycle fee (monitoring, retrieval, fertilization, culture)	$10,000	$15,000
Stimulation medications (gonadotropins, trigger shot, etc.)	$3,500	$7,000
Additional or out-of-network monitoring (labs, ultrasounds)	$500	$2,500
PGT-A — genetic screening of embryos, optional but increasingly standard	$2,500	$6,000
Frozen embryo transfer (FET) — the actual pregnancy attempt	$3,000	$5,500
Total all-in: one fresh retrieval + one FET	$19,500	$36,000

Most patients need more than one retrieval cycle. Feralyx's analysis of CDC ART diagnosis success rates data (360 rows) shows that across all age groups and diagnoses, fewer than half of patients achieve a live birth from a single egg retrieval.

Here's the worked example that reframes the clinic selection decision entirely.

You're 38 years old, diagnosed with diminished ovarian reserve (lower egg count for your age), and comparing two clinics:

• Clinic A (budget): $12K base quote, all-in ~$28K per cycle, per-cycle live birth rate for your age and diagnosis: 19%
• Clinic B (premium): $17K base quote, all-in ~$36K per cycle, per-cycle live birth rate for your age and diagnosis: 34%

Cumulative probability of live birth across 2 cycles:

• Clinic A: 1 - (0.81 × 0.81) = 1 - 0.656 = 34.4%
• Clinic B: 1 - (0.66 × 0.66) = 1 - 0.436 = 56.4%

Expected total spend to live birth (accounting for each clinic's success rate):

• Clinic A expected cycles to success: ~5.3 → $148,400 expected total spend
• Clinic B expected cycles to success: ~2.9 → $104,400 expected total spend

The "cheaper" clinic costs you an expected $44,000 more across your full treatment journey — because a lower per-cycle success rate means statistically more cycles. This is the kind of analysis Feralyx runs for you — so you don't have to build the spreadsheet from scratch yourself.

How Age and Diagnosis Change Which Clinic Is Worth More

The success rate gap between clinics doesn't affect every patient the same way. Your age and diagnosis determine how much that gap actually costs you.

At 35 or younger: Feralyx's CDC ART data shows top-quartile clinics achieving 50%+ live birth rates per retrieval. If your ovarian reserve is normal, even an average clinic at 38% per cycle yields a 62% cumulative probability over two cycles. The premium for the best clinic is real but less financially decisive.

At 38: The math shifts hard. A 38-year-old with low AMH at an average clinic might see 18–22% per cycle. At a top clinic managing the same diagnosis with an aggressive, individualized stimulation protocol, that figure can reach 30–38%. Across two cycles, that gap represents the difference between a 34% and 57% cumulative probability — and tens of thousands of dollars.

At 40–42: Cumulative outcomes across 2–3 cycles at lower-performing clinics can fall below 25% for patients with normal ovarian reserve — and significantly lower for those with diminished reserve or additional diagnoses. Our full cumulative live birth rate breakdown at 35, 38, and 41 shows exactly how to model your personal probability across multiple cycles before committing to a clinic.

Lab Quality, Automation, and the Safety Data SART Doesn't Publish

One variable that rarely appears on a clinic's website or in their SART report: the degree to which they've automated their embryology lab versus maintaining experienced human oversight at every critical step.

This matters more than most patients know. Healthcare broadly is grappling with automation risk — the same systems designed to reduce error can, when improperly validated or inadequately staffed around, introduce new failure modes that aggregate statistics don't surface until patterns emerge. A clinic's SART-reported success rate represents last year's outcomes. It doesn't capture recent embryologist turnover, lab equipment changes, or newly introduced culture media protocols that haven't yet had time to register in published data.

Questions worth asking during your clinic consultation:

• What is your embryo freeze-to-thaw survival rate? (National average: 80–85%; top labs: 90%+)
• What percentage of cycles are cancelled before retrieval, and what are the primary reasons?
• How many embryologists are on staff, and what is your staff-to-cycle volume ratio?
• Do you use time-lapse imaging to continuously monitor embryo development?

These questions won't appear in SART reports. They're exactly the kind of qualitative signals that FertilityIQ patient reviews surface — and they often explain why two clinics with similar reported success rates produce meaningfully different outcomes for patients with comparable profiles. Medication costs are another area where small choices compound: Feralyx's medication_costs dataset shows a $3,500–$7,000 range for stimulation drugs alone, and some patients partially offset these costs through drugstore reward programs or pharmacy discount partnerships — worth confirming directly with your clinic's preferred pharmacy.

The Three Numbers to Compare Before You Commit

Based on Feralyx's analysis of 10,467 data points across seven sources — including CDC ART IVF success rates (2,880 rows), diagnosis-specific outcomes (360 rows), and FertilityIQ cost data (600 rows) — here is the minimum comparison framework:

1. Age-specific live birth rate per intended retrieval Not per transfer. Not per cycle started. Per intended retrieval, for your age bracket. This is the SART metric least susceptible to cherry-picking.

2. Cycle cancellation rate Available in SART supplemental tables. A rate above 10% for patients in your age and diagnosis category warrants a direct conversation about stimulation protocol flexibility before you sign anything.

3. All-in cost per cycle, not base quote Take any clinic's quoted fee and add: $5,250 (medication midpoint per Feralyx's medication_costs data), $1,500 (monitoring average), $4,500 (PGT-A, if applicable), $4,000 (FET). Compare this real number against the clinic's live birth rate — not their headline price.

You can model all three of these variables against your personal situation at Feralyx.

Don't Forget the Insurance Variable

Your all-in cost calculation shifts significantly depending on state insurance mandates and how your employer plan is structured. Feralyx's state_fertility_mandates dataset (51 rows, sourced from RESOLVE's state-by-state coverage database) shows that 21 states have some form of fertility insurance mandate — but whether that mandate applies to your specific plan depends on whether your employer is fully insured (mandate applies) or self-insured under ERISA (mandate legally does not apply).

Patients in mandate states with ERISA-governed employer plans can face the same $28K–$45K out-of-pocket exposure as those in states with no mandate at all. This is a variable that needs to be confirmed with HR and your insurer before you choose a clinic. For a complete breakdown of what your state mandate does and doesn't cover, our IVF insurance coverage and ERISA loophole guide walks through every scenario. And as we covered in IVF Live Birth Rates at 35, 38, and 41: How to Read SART Clinic Data Before Committing to a $25K Cycle, your insurance situation should be confirmed before — not after — you choose which clinic's SART data to dig into.

The Comparison Nobody Builds — Until It's Too Late

Most fertility patients choose a clinic based on geography, a referral from an OB-GYN, or a website that looked competent. They don't build the success-rate-versus-total-cost comparison until a cycle has already failed and they're sitting across from a new doctor trying to understand what went differently.

You deserve that comparison before cycle one.

The 30% SART success rate gap between top and bottom quartile clinics, combined with a $15K–$30K all-in cost spread, makes clinic selection the single highest-leverage financial decision in your fertility journey — more than medication choice, more than financing structure, more than insurance appeals.

Before you sign a financial consent form at any clinic, know their age-specific live birth rate per intended retrieval, their cycle cancellation rate, and your genuine all-in cost. Then run the cumulative probability math across the 1–3 cycles your statistical profile suggests you may need. The numbers will tell you something that no clinic's sales coordinator will.

Feralyx exists because that analysis shouldn't require a statistics degree, three hours on SART's website, and a custom spreadsheet. It should be something every patient has in hand before walking into a consultation — not after writing the first $28,000 check.

Sources

• Discover 5% Bonus Categories, Q3 2026: Gas/EV, Transit, Flights, Drugstores — NerdWallet Health
• Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings — KFF Reproductive Health
• In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles — KFF Reproductive Health
• Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale — KFF Reproductive Health
• Readers Address Drugged Driving, Suicide Prevention, Worker Shortages — KFF Reproductive Health